首页> 外文期刊>Innovations in food technology >Alland Robert announces that acacia gum has growth opportunities, following the decision of the American Food Drug Administration (FDA) to recognize the dietary fiber status of acacia gum
【24h】

Alland Robert announces that acacia gum has growth opportunities, following the decision of the American Food Drug Administration (FDA) to recognize the dietary fiber status of acacia gum

机译:Alland Robert announces that acacia gum has growth opportunities, following the decision of the American Food Drug Administration (FDA) to recognize the dietary fiber status of acacia gum

获取原文
获取原文并翻译 | 示例
           

摘要

International leader in natural gums Alland & Robert is delighted that acacia gum can be classified as a fiber for nutrition labelling purposes in the United States. This will create new product development opportunities for acacia gum worldwide. This decision from the FDA was made public on December 17, 2021, and will consequently allow acacia gum to count as a dietary fiber on American Nutrition and Supplement Facts labels. Acacia gum is an ingredient or additive used worldwide in a wide range of products. Strong scientific literature demonstrates that acacia gum is a fiber. With this decision, the FDA agrees that acacia gum has physiological effects beneficial to human health, such as the reduction of blood glucose and insulin levels after it is eaten with a meal containing a carbohydrate that raises blood glucose levels. Alland & Robert, along with a work group of other acacia gum stakeholders, has submitted two science-backed citizen petitions in 2019 and 2020, in order to provide the FDA with data showing proof that acacia gum has indeed "physiological benefits to human health". "Working collabora-tively has been a great experience and a proof that when all stakeholders pull together, it is a great way to meet one common goal." commented Charles Alland, Deputy General Director at Alland & Robert. Indeed, the work group collaboratively funded and submitted the citizen petitions, and worked with American universities to create the clinical studies that were submitted to the FDA.

著录项

  • 来源
    《Innovations in food technology》 |2022年第94期|19-21|共3页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 英语
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号